3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Diamyd Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes Placebo GABA and Placebo GAD-alum, GABA and Placebo GAD-alum, Active Oral GABA and Active GAD-alum injection - Type I Diabetes | Phase 1 | Completed | University of Alabama at Birmingham | 101 | 2015-01-01 | 2022-05-06 |
| NP2 Enkephalin For Treatment of Intractable Cancer Pain NP2, Placebo - Intractable Pain, Neoplasms | Phase 2 | Completed | Diamyd Inc | 33 | 2011-01-01 | 2014-08-08 |
| Gene Transfer for Cancer Pain NP2 - Cancer Pain | Phase 1 | Completed | Diamyd Inc | 10 | 2008-02-01 | 2014-02-19 |
Pain (2) · Cancer Pain (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Neoplasms (1) · Pain, Intractable (1)
United States (3)
Darren Wolfe, Ph.D. (1) · David Fink, M.D. (1) · David J Fink, MD (1) · Gail Mick, MD (1) · Kenneth McCormick, MD (1)